Video & Podcasts
Video & Podcasts
Pain Week 2023
September 2023
View our video from Pain Week 2023 in Las Vegas.
Drug Discovery World
Dr Lynn Kirkpatrick explains PF614-MPAR
Ensysce CEO, Dr. Lynn Kirkpatrick speaks with Megan Thomas of Drug Discovery World about Ensysce next generation opioids and explains PF614-MPAR, which just received FDA Breakthrough status.
Stock Day Podcast
Dr. Lynn Kirkpatrick talks about TAAP, MPAR and pain relief products
Stock Day Media – Dr. Lynn Kirkpatrick, Ensysce CEO, discusses the next generation of pain relief products, TAAP and MPAR plus a new collaboration designed to expand the Ensysce product portfolio.
Stock Day Media has the mission to bridge the gap between publicly traded small cap companies and investors via an aggregated news service.